# Pharmacokinetics, Pharmacodynamics, and Impact of Inorganic Nitrate on Exercise in HFpEF

> **NCT02256345** · PHASE2 · COMPLETED · sponsor: **University of Pennsylvania** · enrollment: 12 (actual)

## Conditions studied

- Heart Failure
- Diastolic Heart Failure

## Interventions

- **DRUG:** KNO3
- **DRUG:** KCl

## Key facts

- **NCT ID:** NCT02256345
- **Lead sponsor:** University of Pennsylvania
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-01
- **Primary completion:** 2016-06
- **Final completion:** 2016-06
- **Target enrollment:** 12 (ACTUAL)
- **Last updated:** 2017-10-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02256345

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02256345, "Pharmacokinetics, Pharmacodynamics, and Impact of Inorganic Nitrate on Exercise in HFpEF". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02256345. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*